C42: The impact of exercise tolerance on erectile dysfunction treatment in patients after coronary angioplasty

2014 ◽  
Vol 13 (6) ◽  
pp. e1238
Author(s):  
M. Rzepecki ◽  
L. Bryniarski ◽  
T. Drewniak ◽  
K.Z. Juszczak ◽  
P. Maciukiewicz
2016 ◽  
Vol 28 (5) ◽  
pp. 167-171
Author(s):  
R I Clavijo ◽  
T Daskivich ◽  
L Kwan ◽  
J Bassett ◽  
T Keller ◽  
...  

ESC CardioMed ◽  
2018 ◽  
pp. 1030-1035
Author(s):  
Mike Kirby ◽  
Jonny Coxon

It should not be presumed that male patients with cardiovascular disease are less sexually active than others, but they are more likely to have erectile dysfunction. It is therefore crucial to consider the impact on sexual function of medications commonly used to treat cardiovascular disease, because negative effects on erectile dysfunction can lead to problems with compliance and quality of life. Cardiovascular implications of phosphodiesterase type 5 inhibitors used to treat erectile dysfunction should be borne in mind. Effective treatment of the cardiac condition should always take priority.


2013 ◽  
pp. 567-602
Author(s):  
John Reynard ◽  
Simon Brewster ◽  
Suzanne Biers

Physiology of erection and ejaculation 568 Erectile dysfunction: evaluation 572 Erectile dysfunction: treatment 576 Peyronie’s disease 580 Priapism 584 Retrograde ejaculation 588 Premature ejaculation 590 Other disorders of ejaculation and orgasm 592 Late-onset hypogonadism (LOH) 594 Hypogonadism and male hormone replacement therapy 596 Urethritis 600...


Author(s):  
Robert J. Ostfeld ◽  
Kathleen E. Allen ◽  
Karen Aspry ◽  
Eric J. Brandt ◽  
Aaron Spitz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document